Best Liver Cancer Doctors Abroad for Australian Patients

Professor Bulent Karagoz has written over 40 research publications and leads complex liver cancer cases at the Johns Hopkins-affiliated Anadolu Medical Center.

• Specialises in immunotherapy and targeted therapies that use the body's immune system to attack tumours
• Manages multifocal hepatocellular carcinoma and cases complicated by viral hepatitis C or cirrhosis
• Expert in tumour biology, focusing on how liver cancer cells grow and spread
• Member of the European Head and Neck Society and Turkish Medical Oncology Association

Dr Eda Tanrikulu is a high-ranking medical oncologist at Anadolu Medical Center who placed 3rd nationally in Turkey's prestigious minor specialty exam.

• Specialises in medical oncology and chemotherapy for gastrointestinal tumours
• Completed a colorectal cancer exchange programme in Shanghai to refine treatment methods
• Trained at Oxford University in England for metastatic cancer management
• Serves as a lead researcher in international clinical trials for new cancer therapies
• Member of the American Society of Clinical Oncology (ASCO)

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Dr. Murat Dokdok is a specialized interventional radiologist at Anadolu Medical Center. He completed an interventional neuroradiology fellowship at the University Hospital of Zurich. Dr. Dokdok also held a fellowship at Harvard Medical School. He focuses on neurological therapy and imaging for conditions like cerebral aneurysms and liver cancer. Dr. Dokdok works at Anadolu, a facility affiliated with Johns Hopkins Medicine.

• Holds over 100 national and international scientific publications and presentations.
• Certified by the European Society of Neuroradiology.
• Member of the Cardiovascular and Interventional Radiology Society of Europe.
• Performs radiofrequency ablation and chemoembolization for oncology patients.

Dr. Banu Atalar is a professor and radiation oncologist at Anadolu Medical Center. She is an Honorary Fellow of the American College of Radiology (H.FACR). She completed a clinical research fellowship in stereotactic radiosurgery at Stanford University. Stereotactic radiosurgery and MR-guided adaptive SRS make up 75% of her clinical practice.

• President of the Turkish Society for Radiation Oncology.
• Chair of the ESTRO National Societies Committee.
• Recipient of the ASCO International Development and Education Award.
• Author of over 70 international peer-reviewed publications.

Dr. Huseyin Baloglu is a pathologist at Anadolu Medical Center in Turkey. He leads liquid biopsy and precision oncology services. Dr. Baloglu holds a patent for molecular diagnostics in thyroid cancer treatment. He completed training at Albert Einstein College of Medicine and Heidelberg University.

• Authored over 600 peer-reviewed publications in molecular and surgical pathology.
• Specializes in tumor biopsy, immunohistochemistry, and genetic mutation testing.
• Treats complex oncological cases, including glioblastoma and rare sarcomas.
• Works at Anadolu Medical Center, a facility affiliated with Johns Hopkins Medicine.

Dr. Onder Surgit is a professor of general surgery at Optimed International Hospital. He is a surgical instructor at the Advanced Medical Technologies Training Center (ITEM). Dr. Surgit treats cancer, obesity, and complex gastrointestinal conditions. He applies laparoscopic techniques for weight loss and tumor removal.

• Specializes in bariatric surgery including gastric sleeve, bypass, and balloon procedures.
• Performs oncological surgeries for breast, lung, stomach, and colon cancer.
• Served as a faculty member at Turgut Ozal and Atilim Universities.
• Works at AACI-accredited Optimed International Hospital in Tekirdag, Turkey.